For The Better

The endpoint security specialist was hit with an analyst downgrade. But the devil is in the details.

A new CEO with an impressive record is giving investors hope for a rapid turnaround for the heart monitor maker.

The company released data for two drug programs and missed its goals on both.

CrowdStrike continues to grow its business at a rapid pace.

Dry bulk rates take a turn for the better.

Here’s why the automaker is declining even as the Dow jumps.

Profit taking in the cryptocurrency industry is temporarily picking up steam.

Primary voting suggests voters will show Peronists the exit in Argentina.

Is Intel preparing to undercut Nvidia on graphics chip prices?

Barron’s and Cowen deliver a one-two punch to the high-flying rocket stock.

This Southeast Asian e-commerce upstart is raising even more cash for its ambitious expansion plans.

You might think that neither of these companies is an obvious pick to be a big winner when growth gets rolling again — but look closer.

The space tourism company gave investors some not-so-great news.

Zoll Medical plans to acquire the small producer of medical devices.

The company could be a beneficiary of insourcing trends.

The gaming market is expected to grow at a substantial level for the foreseeable future.

Investors are wary of China’s latest EV policy direction.

They’re not complicated companies. They’re just simple, cash-driving business being very well run.

A lost supply agreement for a partner’s COVID-19 vaccine is hurting the biotech’s shares today.

By starting early and investing consistently, teachers have a reasonable path to a potential multimillion-dollar nest egg.